Related Experiment Video
Updated: Feb 2, 2026

Chondrogenic Differentiation Induction of Adipose-derived Stem Cells by Centrifugal Gravity
Published on: February 24, 2017
The Influence of TGF-β3, EGF, and BGN on SOX9 and RUNX2 Expression in Human Chondrogenic Progenitor Cells
Jerome Nicolas Janssen1, Sarah Batschkus2, Stefan Schimmel1
1Tissue Regeneration Work Group, Department of Prosthodontics.
Abstract:
Osteoarthritis (OA) is the most common chronic joint disease and leads to the degradation of the extracellular matrix by an imbalance between anabolic and catabolic processes. TGF-β3 (transforming growth factor beta-3) and epidermal growth factor (EGF) influence the osteochondrogenic potential of chondrocytes. In this study, we compared the expression of mediators and receptors in the TGF-β3 and EGF pathways, as well as biglycan (BGN), in healthy and diseased chondrocytes. Furthermore, we used chondrogenic progenitor cells (CPCs) for in vitro stimulation and knockdown experiments to elucidate the effects of TGF-β3 and EGF on the chondrogenic potential. Our results demonstrate that the expression of TGF-beta receptor type-1 (TGFBRI) and epidermal growth factor receptor (EGFR) is altered in diseased chondrocytes as well as in CPCs. Moreover, TGF-β3 and EGF stimulation influenced the expression levels of BGN, SRY (sex determining region Y)-box 9 (SOX9), and Runt-related transcription factor 2 (RUNX2) in CPCs. Therefore, changes in TGFBRI and EGFR expression likely contribute to the degenerative and regenerative effects seen in late stages of OA.
Insights
Transforming growth factor beta-3 (TGF-β3) and epidermal growth factor (EGF) impact cartilage health. Altered TGF-β3 and EGF receptor expression in osteoarthritis may drive disease progression and regeneration.
Area of Science:
- Biomedical research
- Cell biology
- Orthopedics
Background:
- Osteoarthritis (OA) is a prevalent joint disease characterized by extracellular matrix degradation due to an anabolic-catabolic imbalance.
- Chondrocytes, the cells within cartilage, are influenced by transforming growth factor beta-3 (TGF-β3) and epidermal growth factor (EGF) regarding their osteochondrogenic potential.
Purpose of the Study:
- To compare the expression of mediators and receptors in TGF-β3 and EGF pathways, and biglycan (BGN), in healthy versus diseased chondrocytes.
- To investigate the effects of TGF-β3 and EGF on chondrogenic progenitor cells (CPCs) using in vitro stimulation and knockdown experiments.
Main Methods:
- Comparative analysis of mediator and receptor expression in healthy and OA chondrocytes.
- In vitro stimulation and knockdown experiments on chondrogenic progenitor cells (CPCs).
- Assessment of gene expression for key chondrogenic markers (BGN, SOX9, RUNX2).
Main Results:
- Expression of TGF-beta receptor type-1 (TGFBRI) and epidermal growth factor receptor (EGFR) was altered in both diseased chondrocytes and CPCs.
- TGF-β3 and EGF stimulation modulated the expression of biglycan (BGN), SOX9, and RUNX2 in CPCs.
- Changes in TGFBRI and EGFR expression are implicated in the degenerative and regenerative processes observed in advanced OA.
Conclusions:
- Altered TGFBRI and EGFR expression in chondrocytes and CPCs may play a significant role in osteoarthritis pathogenesis.
- TGF-β3 and EGF signaling pathways are critical regulators of chondrogenic potential and extracellular matrix production in OA.
- Targeting TGF-β3 and EGF pathways could offer therapeutic strategies for osteoarthritis treatment.
Related Concept Videos
Cell Specific Gene Expression
Cell Specific Gene Expression
TGF - β Signaling Pathway
Differentiation of Common Myeloid Progenitor Cells
The Influence of Affect on Cognition
The Influence of Cognition on Affect

